| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oncoprotect Senosan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 46.310 | 45.837 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Inventories | 4.222 | 4.179 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 42.070 | 41.641 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cash | 18 | 18 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -91.622 | -90.688 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Social Capital | 45 | 45 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Debts | 136.888 | 136.896 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 1.418 | 1.404 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Oncoprotect Senosan S.r.l.